Immunocytochemistry staining enables the distinction of atypical meningiomas from gliomas, neurogenic tumors, mesenchymal tumors, and some metastatic tumors with epithelial membrane antigen (EMA), with vimentin being the preferred diagnostic marker for meningiomas [43,44]. This evidence concerns the gene MUC1 and metastatic neoplasm.